Generation Investment Management has led the Swisscom-backed genomic testing platform developer's latest round, boosting its overall funding to $140m.

Switzerland-based genomics technology provider Sophia Genetics, which counts telecommunications firm Swisscom among its shareholders, has raised $77m in funding from new and existing investors. Investment firm Generation Investment Management led the round, which included private equity firm Idinvest Partners, venture capital firm Balderton Capital and Alychlo, the investment vehicle for pharmaceutical entrepreneur Marc Coucke. Founded…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.